Research Article
[Retracted] KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment
Table 1
Relationships of KIF11 and clinicopathological characteristics in 71 patients.
| Feature | All | KIF11 expression | | | Low | High | | | | | |
| Age (year) | | | | 2.045 | 0.153 | <45 | 24 | 7 | 17 | | | ≥45 | 47 | 7 | 40 | | | Gender | | | | 1.701 | 0.192 | Male | 14 | 5 | 9 | | | Female | 57 | 9 | 48 | | | T stage | | | | 6.751 | 0.009 | T1-T2 | 29 | 10 | 19 | | | T3-T4 | 42 | 4 | 38 | | | Lymph node metastasis | | | | 0.031 | 0.860 | Yes | 34 | 7 | 27 | | | No | 37 | 7 | 30 | | | Intraglandular dissemination | | | | 6.675 | 0.010 | Yes | 32 | 2 | 30 | | | No | 39 | 12 | 27 | | |
|
|